Lexeo Therapeutics (LXEO) Stock Insights
LXEO$3.06-0.07 -2.23%
$251.20M
Market Cap
—
P/E
—
Forward P/E
—
Score
Lexeo Therapeutics (LXEO) Stock Insights
LXEO price $3.06 -0.07 -2.23%
- Ticker
- LXEO
- Price
- $3.06
- Change
- -0.07 -2.23%
- Market cap ?
- $251.20M
- Sector
- Healthcare
- Industry
- Biotechnology
Lexeo Therapeutics, Inc. is a genetic medicine firm currently in the clinical development phase, dedicated to addressing both inherited and acquired medical conditions. Its robust pipeline features several gene therapy candidates. These include LX2006, an AAVrh10-based therapy aimed at treating cardiomyopathy linked to Friedreich's ataxia (FA); LX2020, another AAVrh10-based candidate targeting arrhythmogenic…
Insights · Dividends · Forecast · Financials · Learn